期刊文献+

HPLC法测定利福昔明干混悬剂中利福昔明的含量 被引量:4

Determination of rifaximin in Rifaximin Dry Suspension by HPLC
下载PDF
导出
摘要 目的:建立高效液相色谱法测定利福昔明干混悬剂中利福昔明的含量限度的方法。方法:采用高效液相色谱法,色谱柱为Kromasil C8,甲醇-乙腈-0.075mol/L磷酸二氢钾溶液-1.0mol/L枸橼酸溶液(50∶22.5∶22.5∶5)为流动相,流速为1.0ml/min,检测波长为240nm。结果:利福昔明在41.02~164.08μg/ml范围内线性关系良好(r=0.99997),平均回收率为99.79%,RSD为1.30%,规定含量限度为90.0%~110.0%。结论:本法准确、灵敏、可靠,能有效地控制该制剂的质量。 Objective: To establish a method for the determination of rifaximin in Rifaximin Dry Suspension by HPLC. Methods: HPLC was used, the chromatographic column was Kromasil Cs, with the methyl alcohol-methyl cyanide -0.075 mol/L potassium dihydrogen phosphate solution-1.0 mol/L citron acid solution (50:22.5:22.5:5) as the mobile phase, the flow rate was 1.0 ml/min, the detective wavelength was set at 240 nm. Results: The calibration curve of rifaximin was linear at the range of 41.02-164.08 μg/ml (r=0.999 97), the average recovery was 99.79%, RSD=1.30%, the content limit was 90.0%- 110.0%. Conclusion: This method is accurate, sensitive and reliable, it can be used for the quality control of this preparation effectively.
作者 尚士光
出处 《中国医药导报》 CAS 2008年第35期27-28,共2页 China Medical Herald
关键词 利福昔明 利福昔明干混悬剂 高效液相色谱法 Rifaximin Rifaximin Dry Suspension HPLC
  • 相关文献

参考文献2

二级参考文献4

  • 1Gillis JC, Bragten RN. Rifaximin, A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria[J]. Drugs, 1995,49(3):467.
  • 2Descombe JJ, Dubourg D, Picard M, et al. Pharmacokinetic study of rifaximin after oral administration in healthy volunteers[J], Int J Clin Pharmacol Res, 1994,14(2) :51.
  • 3US Patent.4,262,123.
  • 4中华人民共和国国家药典委员会.中国药典[s]:二部[M].北京:化学工业出版社,2000.1.306.

共引文献2

同被引文献15

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部